Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. reports on the Ordinary and Extraordinary General Shareholders' Meetings held on April 29, 2025. The filing includes the extract of the minutes from these meetings and the updated Bylaws of the Company. The financial data referenced pertains to the fiscal year ended December 31, 2024.
Key Financial Metrics
- Net Income (FY 2024): R$ 14,437,237,749.00.
- Total Base for Allocation: R$ 20,822,255,485.18 (includes R$ 6,481,320,000.00 adjustment for IAS 29/CPC 42 hyperinflation effects).
- Dividends and Interest on Equity: R$ 10,505,388,233.75 distributed to shareholders.
- Investment Reserves: R$ 10,339,054,767.31 allocated.
- Tax Incentive Reserve: R$ 108,125,431.35 allocated.
- Capital Stock: R$ 58,275,086,270.41, divided into 15,761,638,756 common shares.
- Authorized Capital Increase: Up to 19,000,000,000 shares.
- Management Compensation (FY 2025): Approved up to R$ 249,548,559.00.
- Fiscal Council Compensation (FY 2025): Approved up to R$ 2,455,546.00.
Note: The filing does not provide specific values for revenue, operating margins, cash flow, or total debt.
Material Changes and Corporate Actions
- Profit Allocation: Shareholders approved the allocation of net income for the fiscal year ended December 31, 2024, including a significant portion to Investment Reserves and dividends.
- Bylaws Amendment: The heading of Article 5 of the Bylaws was amended to reflect capital increases approved within the authorized limit.
- Governance Elections: New members were elected to the Fiscal Council, including minority shareholder nominees (Fabio de Oliveira Moser and Nilson Martiniano Moreira) and controlling shareholder nominees (José Ronaldo Vilela Rezende, Elidie Palma Bifano, Emanuel Sotelino Schifferle, and Eduardo Rogatto Luque).
- Attendance: High shareholder participation was recorded, with 92.21% of voting capital present at the Ordinary Meeting and 92.55% at the Extraordinary Meeting.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, revenue outlook, or specific management commentary regarding future market conditions. The document focuses on the ratification of past financial results and corporate governance updates.
Contingencies and Risks: The Bylaws outline standard corporate risk management frameworks, including:
- Requirements for Board approval on debt exceeding 10% of shareholders' equity.
- Procedures for handling conflicts of interest and compliance investigations.
- Legal defense provisions for directors and officers against lawsuits arising from their duties.
Investor Verification Checklist
- Verify the actual cash distribution date and amount per share for the R$ 10.5 billion dividend and interest on equity payment.
- Confirm the specific details of the capital increases reflected in the amended Article 5 of the Bylaws.
- Review the full audited financial statements for FY 2024 to analyze revenue, EBITDA, and debt levels, as this filing only summarizes profit allocation.
- Monitor the implementation of the approved R$ 249.5 million management compensation package for 2025.
- Check for any subsequent filings regarding the utilization of the Investment Reserves (R$ 10.3 billion) for expansion projects.